Basket catheter-guided ultra-high-density mapping of cardiac arrhythmias: A systematic review and meta-analysis
Standard
Basket catheter-guided ultra-high-density mapping of cardiac arrhythmias: A systematic review and meta-analysis. / Alken, Fares Alexander; Chen, Shaojie; Masjedi, Mustafa; Pürerfellner, Helmut; Maury, Philippe; Martin, Claire A.; Sacher, Frederic; Jais, Pierre; Meyer, Christian.
in: FUTUR CARDIOL, Jahrgang 16, Nr. 6, 11.2020, S. 735-751.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Basket catheter-guided ultra-high-density mapping of cardiac arrhythmias: A systematic review and meta-analysis
AU - Alken, Fares Alexander
AU - Chen, Shaojie
AU - Masjedi, Mustafa
AU - Pürerfellner, Helmut
AU - Maury, Philippe
AU - Martin, Claire A.
AU - Sacher, Frederic
AU - Jais, Pierre
AU - Meyer, Christian
N1 - Publisher Copyright: © 2020 Future Medicine Ltd.. All rights reserved.
PY - 2020/11
Y1 - 2020/11
N2 - Aim: Ultra-high-density mapping (HDM) is increasingly used for guidance of catheter ablation in cardiac arrhythmias. While initial results are promising, a systematic evaluation of long-term outcome has not been performed so far. Methods: A systematic review and meta-analysis was conducted on studies investigating long-term outcome after Rhythmia HDM-guided atrial fibrillation (AF) or atrial tachycardia catheter ablation. Results: Beyond multiple studies providing novel insights into arrhythmia mechanisms, follow-up data from 17 studies analyzing Rhythmia HDM-guided ablation (1768 patients, 49% with previous ablation) were investigated. Cumulative acute success was 100/90.2%, while 12 months long-term pooled success displayed at 71.6/71.2% (AF/atrial tachycardia). Prospective data are limited, showing similar outcome between HDM-guided and conventional AF ablation. Conclusion: Acute results of HDM-guided catheter ablation are promising, while long-term success is challenged by complex arrhythmogenic substrates. Prospective randomized trials investigating different HDM-guided ablation strategies are warranted and underway.
AB - Aim: Ultra-high-density mapping (HDM) is increasingly used for guidance of catheter ablation in cardiac arrhythmias. While initial results are promising, a systematic evaluation of long-term outcome has not been performed so far. Methods: A systematic review and meta-analysis was conducted on studies investigating long-term outcome after Rhythmia HDM-guided atrial fibrillation (AF) or atrial tachycardia catheter ablation. Results: Beyond multiple studies providing novel insights into arrhythmia mechanisms, follow-up data from 17 studies analyzing Rhythmia HDM-guided ablation (1768 patients, 49% with previous ablation) were investigated. Cumulative acute success was 100/90.2%, while 12 months long-term pooled success displayed at 71.6/71.2% (AF/atrial tachycardia). Prospective data are limited, showing similar outcome between HDM-guided and conventional AF ablation. Conclusion: Acute results of HDM-guided catheter ablation are promising, while long-term success is challenged by complex arrhythmogenic substrates. Prospective randomized trials investigating different HDM-guided ablation strategies are warranted and underway.
KW - arrhythmia
KW - atrial fibrillation
KW - atrial tachycardia
KW - catheter ablation
KW - high-density mapping
KW - rhythmia
UR - http://www.scopus.com/inward/record.url?scp=85097487595&partnerID=8YFLogxK
U2 - 10.2217/fca-2020-0032
DO - 10.2217/fca-2020-0032
M3 - SCORING: Review article
C2 - 32608246
AN - SCOPUS:85097487595
VL - 16
SP - 735
EP - 751
JO - FUTUR CARDIOL
JF - FUTUR CARDIOL
SN - 1479-6678
IS - 6
ER -
